Leonteq Securities’s Elicio Therapeutics ELTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.4K Hold
20,000
– – ﹤0.01% 835
2026
Q2
$78.2K Buy
+20,000
New +$201K ﹤0.01% 724

Other funds holding ELTX

Leonteq Securities's ELTX Position: Q3 2026 in Review

Leonteq Securities held its Elicio Therapeutics (ELTX) position steady in Q3 2026 at 20,000 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #835.

Leonteq Securities first reported a position in ELTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $78.2K in Q2 2026. 57 funds tracked by Wall St. Rank hold ELTX as of Q3 2026.

  • Leonteq Securities held 20,000 shares of Elicio Therapeutics worth $36.4K as of Q3 2026.
  • Leonteq Securities left its Elicio Therapeutics share count unchanged in Q3 2026.
  • Elicio Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #835 holding.
  • Leonteq Securities first reported a position in Elicio Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Leonteq Securities's Elicio Therapeutics position peaked at $78.2K in Q2 2026.
  • 57 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.